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ABSTRACT 
Objective: This study aimed to develop a new, rapid, robust, effective, inexpensive, and accurate UV-Vis method for the quantification analysis of 
carbamazepine (CBZ) in the carbamazepine-loaded microparticles. 
Methods: CBZ was encapsulated in ethyl cellulose microparticles by a solvent evaporation method using polyvinyl alcohol (PVA) as a stabilizer. 
Methanol was used to dissolve CBZ followed by dilution with distilled water as diluent. CBZ drug, excipients, and microparticles were subjected to 
specificity, solution stability, linearity, precision and accuracy to confirm and ensure the validity of this method. 
Results: The results showed no interference from the excipients in the selected wavelength 286 nm. It was exhibited linearity in the range 2-12 
μg/ml with R2
Conclusion: As a conclusion, CBZ could be quantified from loaded EC microparticles using UV-Vis spectrophotometer at 286 nm. Therefore, this 
method can be used for the quantification analysis of CBZ in CBZ-loaded microparticles can be utilized also as an alternative method to calculate 
CBZ in different dosage forms. 
 = 0.9992. CBZ solution was stable during 24 h. Accuracy and precision were within the accepted limits (100±2%). All results were in 
accordance to the ICH-Q2 guideline. 
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Ultraviolet-visible (UV-vis) spectrophotometry is one of the most 
frequently used techniques in the pharmaceutical analysis. The 
major law which ruled the spectrophotometric quantitative analysis 
is Beer-Lambert law [1-3]. It states that when a beam of light is 
passed through a transparent cell containing a solution of an 
absorbing substance, reduction of the intensity of light may occur 
and mathematically can be expressed in Eqn. 1. 
A = a. b. c Eqn. 1 
Where A is the absorbance (optical density), a is the absorptivity 
or extinction coefficient, b is the path length of radiation over a 
sample (cm), and c is a concentration of solute (substance) in 
solution [4-7].  
Carbamazepine (CBZ) is an anticonvulsant medication used for the 
treatment of seizures, bipolar disorder, neuropathic pain, neuralgia, 
and trigeminal. It works by diminishing nerve impulses that reason 
seizures and agony [8]. The available CBZ dosage forms in the 
market are chewable tablets, suspension, sustained release capsules 
and sustained-releasetablets [9]. 
Several analysis methods were used to quantify CBZ in 
pharmaceutical dosage forms. By using HPLC-UV [10, 11]. CBZ was 
quantified in the plasma using mobile phase of water, methanol, and 
acetonitrile (ACN) using HPLC chromatographic method [12]. UV-vis 
analysis method was used for dissolution test of CBZ sustained-
release tablets in the pharmacopoeia at the wavelength maxima 283 
nm with water as medium [13]. 
The current study was done to validate the spectroscopic method for 
quantification of CBZ in EC microparticles. The UV-Vis spectroscopy 
validation method for CBZ is an ecessary method to ensure the 
proper characterization of CBZ-loaded microparticles especially for 
the encapsulation efficiency and release profile.  
MATERIALS AND METHODS 
Carbamazepine (CBZ) was purchased from Anuja Healthcare Limited 
(Punjab, India). Ethyl cellulose (EC) polymer was purchased from Dow 
Chemicals (Louisiana, Greensburg, USA). Polyvinyl alcohol (PVA) was 
from Merck (Hohenbrunn, Germany). Solvents used in the analysis were 
from Merck (Hohenbrunn, Germany).  
Preparation of carbamazepine microparticles 
Carbamazepine (CBZ) loaded microparticles were prepared by a solvent 
evaporation method [14] using ethyl cellulose (EC) as a polymer, and 
stabilized by utilizing polyvinyl alcohol (PVA). Dichloromethane (DCM) 
and ethyl acetate (EA) were used here as organic phase solvents. EC was 
dissolved in a mixture of DCM: EA (9:1) ratio then 0.2 g of CBZ was 
added to form the organic phase. The aqueous phase was prepared by 
using 0.5% PVA solution. The organic phase was added to the aqueous 
phase and mixed using a mechanical homogenizer at 1000 rpm for 180 
seconds. The resulted single emulsion was kept for 3 h under a magnetic 
stirrer to ensure the complete evaporation of the solvents. CBZ-loaded 
microparticles were collected by filtration and washed with distilled 
water three times followed by oven drying [15, 16]. 
Solution preparation  
A quantity of 0.01 g of carbamazepine (CBZ) weighed accurately and 
transferred to 10 ml volumetric flask, 2 ml of methanol was added to 
dissolve CBZ then diluted up to the mark with distilled water. The 
solution was then filtered utilizing Whatman filter paper No.1 and 
used as a stock standard solution. To prepare test solution, an 
amount of CBZ-loaded microparticles equivalent to 0.022 g of CBZ 
was weighed in a 100 ml volumetric flask then dissolved in a 15 ml 
of methanol and diluted with distilled water up to the mark then 
filtered with Whatman filter paper No.1. 
Spectrophotometric method validation 
The spectrophotometric method was validated as per International 
Conference on Harmonisation (ICH) Q2 guideline. 
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Specificity and solution stability 
Specificity was calculated and confirmed by the comparison of 
carbamazepine (CBZ) ultra-violate (UV) spectrum, ethyl cellulose (EC) 
UV spectrum, and polyvinyl alcohol (PVA) UV spectrum. CBZ standard 
solution of 10 μg/ml was prepared and scanned utilizing double beam 
UV spectrophotometer at a wavelength ranged from 400-200 nm (UV-
1800, Shimadzu, Japan). EC solution was prepared by the dissolving of 
0.5 g EC powder in 90 ml dichloromethane (DCM) under continuous 
stirring, then 10 ml of ethyl acetate solvent was added to produce 
0.5% of EC solution. PVA solution was prepared by dissolving 0.5 g of 
PVA in 100 ml distilled water with heating.  
The maximum wavelength of CBZ was selected after scanning and 
no absorption of the excipients was detected at the same wave 
length. This wavelength was found to be 286 nm (fig. 1). Solution 
stability was evaluated by measuring the absorbance (A286
Accuracy 
) of the 
CBZ solutions at 37°C prepared from the standard solution in 
triplicate (n = 3) at different intervals 0, 1, 3, 6, 12, and 24 h [17, 18]. 
Linearity 
Linearity was evaluated with six different concentrations ranged 
from 2-12 μg/ml which obtained by diluting of carbamazepine (CBZ) 
stock solution with distilled water. The linearity of CBZ equation was 
used to calculate CBZ in the fabricated microparticles [19]. 
The accuracy was measured by calculating the recovery of known 
amounts of carbamazepine (CBZ) added into the dilution medium 
(distilled water). Three concentrations were examined in triplicate, 
namely 17.6 mg/ml, 22 mg/ml and 30.8 mg/ml representing 80%, 
100% and 120% respectively of the original concentration used in 
the preparation of CBZ microparticles [20-22]. 
Precision 
Precision was calculated by measuring nine equalled carbamazepine 
(CBZ) concentrations (22 mg/ml) prepared from a standard solution 
of CBZ. Intermediate precision was confirmed by repeating the 
above step on another day with a different analyst. The relative 
standard deviation (% RSD) was then calculated [23-26]. 
RESULTS AND DISCUSSION  
Developing of a new spectroscopic method for the estimation of 
drugs in its dosage forms has raised recently due to its important 
role in pharmaceutical analysis and development [27]. 
Carbamazepine (CBZ) wave length was selected at 286 nm [28] 
(λmax
 
 = 286 nm, fig. 1), whereas no absorption was detected for ethyl 
cellulose (EC) and polyvinyl alcohol (PVA) excipients at CBZ 
wavelength. This shows that no interference from the excipients at 
the selected wavelength [29, 30]. 
 
Fig. 1: UV-spectrum of carbamazepine (cbz), ethyl cellulose and polyvinyl alcohol (PVA) 
 
Solution stability study revealed that the absorbance of CBZ was 
99% to 100% of the initial value (table 1) with %RSD of 0.144 which 
indicating that the CBZ solution in the water was stable for at least 
24 h. Solution stability is an important criterion to ensure that the 
prepared samples were stable and no changes could affect the 
samples during the test period [31]. 
 
Table 1: Solution stability of carbamazepine in water 
No. Time interval (h) A286 % of initial A286 
1 0 0.579 99.80285 
2 1 0.58 99.97527 
3 3 0.579 99.80285 
4 6 0.579 99.80285 
5 12 0.579 99.80285 
6 24 0.581 100.1477 
Mean= 0.580, SD= 0.0008, % RSD= 0.144. Number of experiments (n) = 3. 
 
Linearity was calculated using six different concentrations from 2-12 
μg/ml. The regression line correlation coefficient (R2) was calculated and 
found to be 0.9992 with ay-intercept of 0.0005. The slope of the linearity 
was 0.0526 (fig. 2). These data showed linear absorbance readings 
through the selected range [32]. The same R2
The recovery of the spiked CBZ added to the medium at 80%. 100% 
and 120% levels found to be 99.81%, 101.33% and (99.62%) 
respectively, with the relative standard deviation (% RSD) less than 
2 (0.97, 0.35 and 0.14 respectively, table 2). This indicates that the 
method was passed the accuracy test [34].  was found by Kumar et al. 
for the determination of benidipine hydrochloride in its dosage-forms by 
using UV-vis spectroscopic method [33]. 
The results of the precision test are shown in table 3. The % RSD was found 
to be 0.41 for the intraday and 0.36 for the interday indicating that the 
Surini et al. 
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precision values of the validated method were within the accepted limits 
[35]. The above-validated method was a simple, rapid, precise, accurate 
and can be used for the estimation of CBZ in the prepared microparticles 
utilizing the same wavelength and same dose for 24 h [36]. 
 
 
Fig. 2: Linearity curve of carbamazepine in distilled water 
 
Table 2: Accuracy study of carbamazepine spiked at different concentrations. 
Recovery level % recovery Mean % recovery SD % RSD 
80% 100.78 99.81 0.96 0.97 
 99.81 
 98.84 
100% 102.33 101.33 0.36 0.35 
 101.47 
 100.18 
120% 99.71 99.62 0.14 0.14 
 99.98 
 99.15 
N (number of experiments) = 3 
 
Table 3: Results of a precision study of carbamazepine at 100% concentration level 
No. % Assay 
Intraday Interday 
1 99.00 98.62 
2 98.62 98.62 
3 98.62 98.62 
4 99.38 99.38 
5 99.77 99.38 
6 99.00 99.00 
7 99.00 98.62 
8 98.62 99.00 
9 99.38 99.38 
Mean 99.04 98.96 
SD= 0.40 (intraday) and = 0.36 (interday). %RSD = 0.41 (intraday), %RSD= 0.36 (interday). Number of experiments (n) = 9. 
 
CONCLUSION  
In this study, a new UV-Vis spectrophotometric method was 
developed and validated to quantify CBZ in EC microparticles as per 
ICH Q2 guideline. The validated method was found to be linear, 
accurate, precise, and stable for 24 h. Therefore, this method can be 
used for quantification analysis of CBZ in CBZ-loaded microparticles 
and can be utilized also as an alternative method to calculate CBZ in 
different dosage forms. 
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